Specimen Validity Testing Industry Outlook 2025-2029: Market Set to Cross $5.76 Billion Milestone

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Specimen Validity Testing Market Size By 2025?
The market for specimen validity testing has seen robust growth in the past few years. There's an anticipated growth from $3.68 billion in 2024 to $4.03 billion in 2025, showing a compound annual growth rate (CAGR) of 9.7%. This growth during the historic period can be credited to factors such as a rise in drug usage, increased frequency of drug testing, strict regulations, a boost in alcohol consumption, and the incorporation of point-of-care testing.

How Big Is the Specimen Validity Testing Market Size Expected to Grow by 2029?
In the coming years, a robust growth is anticipated in the market size of specimen validity testing, with projections estimating it to reach a value of $5.76 billion in 2029, expanding at a CAGR of 9.3%. The projected growth within this forecasted timeline can be credited to an increased demand for drug testing within the workplace, the acceptance and incorporation of oral fluid testing, and a surge in research and development activities. Furthermore, the rising employment of SVT and its broadening application in the field of pain management also contributes to this growth. Some of the significant trends projected for this period include advancements in technology, the use of artificial intelligence in interpreting results, the innovation of products, a rise in partnerships, and the creation of portable testing devices that permit monitoring on the move.

View the full report here:
https://www.thebusinessresearchcompany.com/report/specimen-validity-testing-global-market-report

Which Key Market Drivers Powering Specimen Validity Testing Market Expansion and Growth?
The rise in substance misuse is predicted to fuel the expansion of the specimen validity testing market. Substance misuse entails the regular, excessive, or improper usage of legal or illegal substances for non-medical reasons. Several interconnected factors, such as opioid addiction, escalating mental health disorders, lack of access to treatment and support resources, and societal portrayal, are contributing to the rise of substance misuse. SVT techniques are designed to detect the presence of contaminants and compounds by evaluating several measures including pH, specific gravity, creatinine levels, and temperature. For example, the Office for Health Improvement and Disparities, a UK governmental department, indicated in October 2023 that adult engagements with drug and alcohol programs increased from April 2021 to March 2022, reaching 0.29 million engagements, up from 0.28 million the previous year. Furthermore, in October 2024, according to the Office for National Statistics, another UK government body, England and Wales reported 5,448 drug poisoning-associated deaths in 2023, marking an 11.0% increase from the 4,907 deaths reported in 2022. As a result, the rise in substance misuse is anticipated to boost the expansion of the specimen validity testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15673&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Specimen Validity Testing Market?
Leading firms in the specimen validity testing market are focusing on innovation, creating products like high-resolution urine drug testing profiles in order to remain relevant. These profiles bring a more sophisticated level of drug testing involving advanced analytics. An example of this is Mayo Clinic Laboratories, a medical lab based in the US, which launched a data-led urine drug testing (UDT) profile in July 2022. This innovation aids doctors by offering them crucial information to help manage patients addicted to substances such as prescription opioids, alcohol, marijuana, and nicotine. The novel addiction medicine monitoring profile (Mayo ID ADMPU) aligns with the standards of the American Society of Addiction Medicine. It has superior sensitivity and specificity to identify primary drugs and their metabolites from numerous drug classes, including opioids, benzodiazepines, stimulants, and PCP. Advanced high-resolution, accurate mass spectrometry is used in the profile for targeted and immunoassay testing for specific substances. This supplies healthcare providers with comprehensive, clinically valuable information.

What Are the Emerging Segments in the Specimen Validity Testing Market?
The specimen validity testing market covered in this report is segmented -

1) By Product And Service: Products, Service
2) By Testing Type: Laboratory Testing, Rapid Or Point-Of-Care Testing
3) By End-User: Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Criminal Justice And Law Enforcement Agencies, Other End-Users

Subsegments:
1) By Products: Reagents And Assay Kits, Controls And Calibrators, Specimen Collection Devices, Analyzers And Instruments
2) By Service: Laboratory Testing Services, Point-Of-Care Testing Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15673&type=smp

Who Are the Global Leaders in the Specimen Validity Testing Market?
Major companies operating in the specimen validity testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Medline Industries Inc., Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Alere Inc., Clinical Reference Laboratory Inc., Precision Diagnostics, ACM Global Laboratories, Millennium Health, Omega Laboratories Inc., Dominion Diagnostics, CannAmm, Sciteck Inc., Starplex Scientific Inc., Vision Diagnostics Inc., Premier Biotech Inc., Alfa Scientific Designs, Express Diagnostics, American Bio Medica Corporation, Titan Biotech Ltd., SureHire, Miraclean Technology Co. Ltd

Which are the Top Profitable Regional Markets for the Specimen Validity Testing Industry?
North America was the largest region in the specimen validity testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specimen validity testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15673

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.